Valuation: InterCure Ltd.

Market Cap 173M 51.8B 148M 138M 127M 239M 16.52B 241M 1.64B 637M 8.3B 648M 634M 27.45B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 309M 92.72B 265M 248M 227M 428M 29.57B 432M 2.93B 1.14B 14.85B 1.16B 1.13B 49.14B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day-75.93%
1 week+12.07%
Current month+0.19%
1 month+9.39%
3 months+25.44%
6 months+14.18%
Current year-2.47%
1 week 1,255
Extreme 1255
1,820
1 month 1,255
Extreme 1255
1,820
Current year 1,126.5
Extreme 1126.5
1,820
1 year 1,126.5
Extreme 1126.5
2,850
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 66 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap.
3/18/26 Other

Director

15,000 0.0274%
11/9/22 Option

Chief Financial Officer

230,000 0.5066%
11/9/22 Option 230,000 0.5066%
Change 5-day change 1-year change 3-year change Capi.($)
-75.93%+12.07%-43.08%-44.73% 47.97M
-0.37%+7.11%-8.45%+209.36% 333M
+1.75%+2.96%-20.91%-11.22% 175M
+0.50%+1.01%+6.38%+86.92% 143M
+6.38%+19.05%-30.56%-5.66% 95.51M
-1.69%+3.57%+9.43%+45.00% 53.07M
Average -11.56%+3.26%-14.53%+46.61% 141.13M
Weighted average by Cap. -3.39%+4.57%-11.85%+94.22%

Financials

2024 2025
Net sales 239M 71.69B 205M 192M 175M 331M 22.87B 334M 2.26B 881M 11.48B 897M 877M 38B 270M 81.1B 232M 217M 198M 374M 25.87B 378M 2.56B 997M 12.99B 1.01B 992M 42.98B
Net income -67.8M -20.35B -58.12M -54.39M -49.73M -93.85M -6.49B -94.82M -643M -250M -3.26B -255M -249M -10.79B -35.71M -10.72B -30.61M -28.65M -26.19M -49.44M -3.42B -49.95M -339M -132M -1.72B -134M -131M -5.68B
Net Debt 133M 39.85B 114M 107M 97.38M 184M 12.71B 186M 1.26B 490M 6.38B 498M 488M 21.12B 136M 40.92B 117M 109M 100M 189M 13.05B 191M 1.29B 503M 6.55B 512M 501M 21.69B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-08-24 ILA 1,578.00 +20.37% 246,635
26-08-21 ILA 1,311.00 +1.67% 11,379
26-08-20 ILA 1,289.50 -2.86% 22,313
26-08-19 ILA 1,327.50 -6.28% 31,191
26-08-18 ILA 1,416.50 -0.49% 2,474
  1. Stock Market
  2. Stocks
  3. INCR Stock